About NHIA > Committees > Sterile Compounding Practice Committee

Sterile Compounding Practice Committee

Sterile Compounding Practice

The Sterile Compounding Practice (SCPC) Committee shall advise the home and alternate site infusion industry on scientific and technical issues concerning drug compounding under United States Pharmacopeia (USP) Chapters <797> and <800> as well as sections 503A and 503B of the federal Food, Drug, and Cosmetic Act.
SCPC Chair Barbara Petroff

Barbara Petroff, MS RPh BCSCP FASHP FNHIA

Shawler Petroff LLC
SCPC Vice Chair Glen Gard2

GLEN GARD, CPhT-Adv, CSPT, FNHIA

Option Care Health

Cara Baker, PharmD

Kaiser Permanente

Jessica-Anne Chlebda, CPhT, CSPT

Option Care Health

Gene B. Decaminada, BS Pharm, RPh, FNHIA, FCPA

Yale New Haven Health

Ashley Haddad, CPhT, CSPT

Option Care Health

Daniel Kyes, CPhT, CSPT, BCSCPT, FNHIA

New England Life Care

Devonne Moore, PharmD

KabaFusion Inc.

Shyla Robinson, CPhT, CSPT

Vital Care Infusion Services

Lilit Smith, PharmD

Baptist Health South Florida

Troy Tanner, PharmD, RPh, BCPS

Managed Health Care Associates Inc.

Kelly Taylor, PharmD, BCSCP

Carle Home Infusion

Lisa Tedesco, PharmD, BCSCP

New England Life Care

Samantha Tricarico, CPhT, CSPT

Optum Infusion Pharmacy

Chris Van Raam, PharmD, MBA, BCSCP

ContinuumRx

Shelly Willis, CPhT, CSPT

UC Davis Home Infusion